GE Healthcare has partnered with AliveCor, a US-based medical device and AI company, to enhance patient convenience and help minimise cardiac-related hospitalisations by improving the integration of patient data.

Under the partnership, medical-grade six-lead electrocardiograms (ECGs) taken by patients on an AliveCor KardiaMobile 6L ECG device will be integrated into GE Healthcare’s MUSE Cardiac Management System for physicians to evaluate.

According to GE Healthcare, the integration will help physicians in managing diagnosed cardiac conditions, proving access to trusted patient data and the ability to manage cardiac-related hospitalisations including but not limited to atrial fibrillation.

The AI-enabled KardiaMobile 6L ECG device, approved by the US Food and drug administration (FDA), can detect atrial fibrillation along with other heart rhythm conditions.

GE Healthcare’s MUSE is a cardiac management system that connects with the hospital’s electronic medical record (EMR) for easy transaction and analysis of data resulting in improved patient care.

The integration will help in more efficient and timely care for patients within the 87% of top cardiac hospitals using GE MUSE. The clinician will now have streamlined access to cardiac data from patients from anywhere which will make lifesaving care easy.

GE Healthcare life care solutions business president and CEO Tom Westrick said: “By teaming up with AliveCor, we are strengthening the connection between personal health and clinical decision making to transform cardiac care to be more convenient for patients and actionable for providers.

“The KardiaMobile 6L allows patients to conveniently monitor their heart health in any environment, and by integrating its data directly into MUSE, we are offering hospitals and health systems an unprecedented amount of information to leverage for the patient care within their existing clinical workflow – with the ultimate goal of improving patient outcomes and reducing the number of cardiac-related hospitalisations and the costs associated with them.”

AliveCor CEO Priya Abani said: “Delivering medically validated ECG readings taken with KardiaMobile 6L directly into MUSE can help facilitate closer connection and better communication about treatment and care between physicians and their patients, even when they are not physically together.

“This integration directly supports our mission of transforming cardiology with intelligent, highly personalised heart data and connected cardiac care services by offering providers information that can be integrated seamlessly into their clinical practices, and patients the convenience, privacy, and reliability of ECG readings they can perform at home or on the go.”